Synthesis and Biological Evaluation of Berberine Derivatives as IBS Modulator

Author(s): Xin Deng, Xinxin Zhao, Jing Han, Jingjie Wang, Wenlong Huang, Hai Qian, Liang Ge.

Journal Name: Letters in Drug Design & Discovery

Volume 9 , Issue 5 , 2012

Become EABM
Become Reviewer


Irritable bowel syndrome is the most common functional gastrointestinal disorder characterized by chronic abdominal pain or discomfort in association with a change in bowel habit. 5-HT receptor modulators have been developed as IBS therapeutic agents and proved to be effective in the treatment of the disease. In this letter, 12 berberine derivatives were designed and synthesized as 5-HT receptor modulators. Preliminary biological tests suggested that the new compounds exhibited promising activity for IBS therapy.

Keywords: Irritable bowel syndrome (IBS), Berberine Derivatives, gastrointestinal (GI) disorder, intestinal flora, plasma 5-HT, CMC-Na solution, isoquinoline alkaloid, tetrahydroberineper

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [489 - 493]
Pages: 5
DOI: 10.2174/157018012800389386
Price: $65

Article Metrics

PDF: 19